Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 151

1.

Role of intraventricular sodium nitroprusside in vasospasm secondary to aneurysmal subarachnoid haemorrhage: a 5-year prospective study with review of the literature.

Agrawal A, Patir R, Kato Y, Chopra S, Sano H, Kanno T.

Minim Invasive Neurosurg. 2009 Feb;52(1):5-8. doi: 10.1055/s-0028-1085454. Epub 2009 Feb 26. Review.

PMID:
19247898
2.
3.

Effect of intraventricular sodium nitroprusside on cerebral hemodynamics and oxygenation in poor-grade aneurysm patients with severe, medically refractory vasospasm.

Raabe A, Zimmermann M, Setzer M, Vatter H, Berkefeld J, Seifert V.

Neurosurgery. 2002 May;50(5):1006-13; discussion 1013-4.

PMID:
11950403
6.

Safety of intrathecal sodium nitroprusside for the treatment and prevention of refractory cerebral vasospasm and ischemia in humans.

Thomas JE, Rosenwasser RH, Armonda RA, Harrop J, Mitchell W, Galaria I.

Stroke. 1999 Jul;30(7):1409-16.

7.

Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study.

Ehlert A, Schmidt C, Wölfer J, Manthei G, Jacobs AH, Brüning R, Heindel W, Ringelstein EB, Stummer W, Pluta RM, Hesselmann V.

J Neurosurg. 2016 Jan;124(1):51-8. doi: 10.3171/2014.12.JNS13846. Epub 2015 Jul 10.

PMID:
26162034
8.

Intermittent low dose intrathecal sodium nitroprusside therapy for treatment of symptomatic aneurysmal SAH-induced vasospasm.

Pathak A, Mathuriya SN, Khandelwal N, Verma K.

Br J Neurosurg. 2003 Aug;17(4):306-10.

PMID:
14579895
9.

Feasibility and safety of intrathecal nimodipine on posthaemorrhagic cerebral vasospasm refractory to medical and endovascular therapy.

Hänggi D, Beseoglu K, Turowski B, Steiger HJ.

Clin Neurol Neurosurg. 2008 Sep;110(8):784-90. doi: 10.1016/j.clineuro.2008.05.001. Epub 2008 Jun 12.

PMID:
18554777
10.

The effect of subarachnoid sodium nitroprusside on the prevention of vasospasm in subarachnoid haemorrhage.

Pachl J, Haninec P, Tencer T, Mizner P, Houst'ava L, Tomás R, Waldauf P.

Acta Neurochir Suppl. 2005;95:141-5.

PMID:
16463839
11.

A multimodal concept in patients after severe aneurysmal subarachnoid hemorrhage: results of a controlled single centre prospective randomized multimodal phase I/II trial on cerebral vasospasm.

Hänggi D, Eicker S, Beseoglu K, Behr J, Turowski B, Steiger HJ.

Cent Eur Neurosurg. 2009 May;70(2):61-7. doi: 10.1055/s-0028-1087214. Epub 2009 May 25.

PMID:
19711257
12.

Preventive effect of continuous cisternal irrigation with magnesium sulfate solution on angiographic cerebral vasospasms associated with aneurysmal subarachnoid hemorrhages: a randomized controlled trial.

Yamamoto T, Mori K, Esaki T, Nakao Y, Tokugawa J, Watanabe M.

J Neurosurg. 2016 Jan;124(1):18-26. doi: 10.3171/2015.1.JNS142757. Epub 2015 Jul 31.

PMID:
26230471
13.

Magnesium sulfate therapy after aneurysmal subarachnoid hemorrhage.

Veyna RS, Seyfried D, Burke DG, Zimmerman C, Mlynarek M, Nichols V, Marrocco A, Thomas AJ, Mitsias PD, Malik GM.

J Neurosurg. 2002 Mar;96(3):510-4.

PMID:
11883835
15.
16.

Rise in serum soluble intercellular adhesion molecule-1 levels with vasospasm following aneurysmal subarachnoid hemorrhage.

Mocco J, Mack WJ, Kim GH, Lozier AP, Laufer I, Kreiter KT, Sciacca RR, Solomon RA, Mayer SA, Connolly ES Jr.

J Neurosurg. 2002 Sep;97(3):537-41.

PMID:
12296636
17.
18.

Intra-arterial nimodipine for severe cerebral vasospasm after aneurysmal subarachnoid hemorrhage: influence on clinical course and cerebral perfusion.

Hänggi D, Turowski B, Beseoglu K, Yong M, Steiger HJ.

AJNR Am J Neuroradiol. 2008 Jun;29(6):1053-60. doi: 10.3174/ajnr.A1005. Epub 2008 Mar 27.

19.

[Use of transcranial Doppler in monitoring cerebral vasospasm secondary to subarachnoid hemorrhage].

Radanovic M, Scaff M.

Rev Assoc Med Bras (1992). 2001 Jan-Mar;47(1):59-64. French.

Supplemental Content

Support Center